- Home
- TXMD vs RGTIW Comparison
TXMD vs RGTIW Comparison
Compare TXMD & RGTIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXMD | RGTIW |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | United States |
| Employees | N/A | 164 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | N/A |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | TXMD | RGTIW |
|---|---|---|
| Price | $2.01 | $5.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.3K | ★ 92.6K |
| Earning Date | 05-12-2026 | 03-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.68 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,761,000.00 | ★ $11,892,000.00 |
| Revenue This Year | $427.09 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 35.25 | N/A |
| 52 Week Low | $0.84 | $2.13 |
| 52 Week High | $2.95 | $46.78 |
Technical Indicators
Market Signals| Indicator | TXMD | RGTIW |
|---|---|---|
| Relative Strength Index (RSI) | 33.63 | 40.77 |
| Support Level | $1.05 | $5.07 |
| Resistance Level | $2.05 | $6.63 |
| Average True Range (ATR) | 0.13 | 0.76 |
| MACD | -0.03 | -0.08 |
| Stochastic Oscillator | 20.00 | 29.94 |
Price Performance
Historical ComparisonAbout TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About RGTIW Rigetti Computing Inc.
Rigetti Computing Inc builds quantum computers and the superconducting quantum processors that power them. The Company sells 9-qubit to 108-qubit quantum computing systems under the Novera and Cepheus trade names. Through the Rigetti Quantum Cloud Services (QCS) platform, the Company's machines can be integrated into any public, private or hybrid cloud. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Mumbai, India. The Company's revenue is derived from operations in the United States and the United Kingdom.